Marketwatch Lupin Gains Nearly 1% As Subsidiary Gets New Drug Approval Admin July 2, 2021 The USFDA approved Lupin’s US-based arm’s supplemental new drug application (sNDA) to expand the use of Solosec for treating trichomoniasis in adults, Lupin said NDTV Profit – Latest Share on Facebook Tweet it Pin it Share it Email